Clinical Evidence for a Bacillus coagulans–Centered Probiotic Composition in Metabolic-Environment Regulation and Weight Management Among Overweight Adults

Abstract

Background: We sought to produce a ready manuscript on a Bacillus coagulans-centered probiotic composition while preserving the original quantitative matrix and figures associated with the composition. Methods: We integrated published randomized trials and evidence syntheses on Bacillus coagulans-containing interventions with the composition-linked comparative matrix retained in the manuscript package. Results: Published human evidence shows that probiotic interventions can produce modest but reproducible reductions in body weight, body mass index, waist circumference and selected metabolic markers over 8-12 weeks, particularly at adequate dose and duration [1-8]. Direct Bacillus coagulans-related trials support reductions in visceral fat, body weight or subgroup weight loss, whereas SCFA-oriented analyses support the biological plausibility of insulin-sensitivity improvement [2,3,8]. The retained composition-linked comparative matrix showed the same directional pattern across body weight, waist circumference, body fat, triglycerides, HOMA-IR, fecal SCFA index and responder rate. Conclusions: When read together, published clinical trials and the preserved composition-linked quantitative matrix support a coherent translational rationale for this Bacillus coagulans-based weight-management formulation.